Skip to main content

Table 2 Isolated microorganisms by treatment group

From: The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients

Characteristic PMX-HP group (n = 29) Non PMX-HP group (n = 30) Overall (N = 59) P valuea
Organism
 Gram-positive bacteria 7 (23%) 2 (7%) 9 (15%) 0.15
 Gram-negative bacteria 13 (43%) 18 (60%) 31 (53%) 0.20
 Fungal infection 1 (3%) 2 (7%) 3 (5%) 1.00
 Mycobacterium 1 (3%) 0 (0%) 1 (2%) 1.00
 Other 0 (0%) 1 (3%) 1 (2%) 1.00
Site of infection     
 Central nervous system 2 0 2 (3%) 0.14
 Respiratory tract 6 12 18 (31%) 0.11
 Gastrointestinal tract 9 6 15 (25%) 0.33
 Genitourinary tract 3 3 6 (10%) 0.97
 Musculoskeletal 0 3 3 (5%) 0.08
 Systemic infection 5 4 9 (15%) 0.68
 Other 5 3 8 (14%) 0.42
  1. Data represent sample size and column percentage
  2. PMX-HP polymyxin B hemoperfusion
  3. aFisher’s exact test for categorical variables; Student’s t test or Kruskal–Wallis test for continuous variables